SCHEMBL31688348

SCHEMBL31688348

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ VIPR1 P32241 3/20 0.45
▸ VIPR2 P41587 4/20 0.45
▸ PTH1R Q03431 2/20 0.44
▸ ECE1 P42892 1/20 0.43
▸ GLP1R P43220 1/20 0.43
▸ MUS81 Q96NY9 1/20 0.43
▸ MAPK8 P45983 1/20 0.43
▸ MAPK9 P45984 1/20 0.43
▸ MAPK10 P53779 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ IL23R Q5VWK5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31688351 0.93 GLP1R (0.43) VIPR1VIPR2PTH1RECE1GLP1R
SCHEMBL31307229 0.88 GLP1R (0.51) VIPR1VIPR2PTH1RECE1GLP1R
SCHEMBL30513846 0.87 VIPR1 (0.60) VIPR1VIPR2PTH1RECE1GLP1R
SCHEMBL30432328 0.87 BACE1 (0.46) —
SCHEMBL29650465 0.87 VIPR1 (0.52) VIPR1VIPR2IL23R
SCHEMBL30168735 0.87 TFPI (0.52) VIPR1PTH1RRXFP1
SCHEMBL30974217 0.87 PDCD1LG2 (0.45) —
SCHEMBL30168700 0.86 RXFP1 (0.51) VIPR1VIPR2PTH1RRXFP1IL23R
SCHEMBL31654013 0.86 IL23R (0.48) IL23R
SCHEMBL29757690 0.86 MAPK8 (0.47) VIPR1VIPR2ECE1GLP1RMUS81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250297282-A1 VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE JUNO THERAPEUTICS GMBH (DE) 2025-09-25 — — US disclosed
Send feedback